ArticleActa pharmacologica Sinica2024

Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren's syndrome in mice by promoting TEC kinase degradation.

Ya-Qi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.